Trials / Completed
CompletedNCT04783207
Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance in Athletes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Amazentis SA · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized, double-blind, placebo-controlled study enrolling 36 (16 Elite and 20 Sub-Elite trained endurance runners (18 placebo and 18 Mitopure intervention) who are 18-40 years of age. Mitopure or Placebo supplement, will be given as a daily oral dose for 4-weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Mitopure | Softgel containing 250 mg of Urolithin A (Mitopure) with excipients. 4 soft-gels to be taken daily |
| DIETARY_SUPPLEMENT | Placebo | Softgel containing only excipients. 4 soft-gels to be taken daily |
Timeline
- Start date
- 2021-04-21
- Primary completion
- 2022-05-30
- Completion
- 2023-08-30
- First posted
- 2021-03-05
- Last updated
- 2023-08-31
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04783207. Inclusion in this directory is not an endorsement.